title: Progesterone concentrations, exogenous equine chorionic gonadotropin, and timing of prostaglandin F(2alpha) treatment affect fertility in postpuberal Nelore heifers.
abstract: Two experiments were performed to test the hypothesis that elevated progesterone concentrations impair pregnancy rate to timed artificial insemination (TAI) in postpuberal Nelore heifers. In Experiment 1, postpuberal Nelore heifers (n=398) received 2mg estradiol benzoate (EB) and either a new progesterone-releasing intravaginal device containing 1.9g of progesterone (CIDR) (first use) or a CIDR previously used for 9 d (second use) or for 18 d (third use) on Day 0, 12.5mg prostaglandin F(2alpha) (PGF(2alpha)) on Day 7, 0.5mg estradiol cypionate (ECP) and CIDR withdrawal on Day 9, and TAI on Day 11. Largest ovarian follicle diameter was determined on Day 11. The third-use CIDR treatment increased largest ovarian follicle diameter and pregnancy rate. Conception to TAI was reduced in heifers with smaller follicles in the first- and second-use CIDR treatments, but not in the third-use CIDR treatment. In Experiment 2, postpuberal Nelore heifers received the synchronization treatment described in Experiment 1 or received 12.5mg PGF(2alpha) on Day 9 rather than Day 7. In addition, 50% of heifers received 300 IU equine chorionic gonadotropin (eCG) on Day 9. Heifers were either TAI (Experiment 2a; n=199) or AI after detection of estrus (Experiment 2b; n=125 of 202). In Experiment 2a, treatment with eCG increased pregnancy rate to TAI in heifers that received PGF(2alpha) on Day 9 but not on Day 7 and in heifers that received a first-use CIDR but not in heifers that received a third-use CIDR. Treatments did not influence reproductive performance in Experiment 2b. In summary, pregnancy rate to TAI in postpuberal Nelore heifers was optimized when lower concentrations of exogenous progesterone were administered, and eCG treatment was beneficial in heifers expected to have greater progesterone concentrations.
authors.affiliation: Departamento de Produção Animal, Faculdade de Medicina Veterinária e Zootecnia, FMVZ-UNESP, CEP 18618-000, Botucatu, SP, Brazil.
authors.forename: C C
authors.initials: CC
authors.lastname: Dias
authors.forename: F S
authors.initials: FS
authors.lastname: Wechsler
authors.forename: M L
authors.initials: ML
authors.lastname: Day
authors.forename: J L M
authors.initials: JL
authors.lastname: Vasconcelos
mesh_terms: D000818:Animals; D002417:Cattle / Q000097:blood / Q000502:physiology*; D015237:Dinoprost / Q000494:pharmacology / Q000627:therapeutic use*; D004973:Estrus Synchronization / Q000379:methods; D005260:Female; D005298:Fertility / Q000187:drug effects* / Q000502:physiology; D006064:Gonadotropins, Equine / Q000494:pharmacology / Q000627:therapeutic use*; D007315:Insemination, Artificial / Q000379:methods / Q000662:veterinary; D009994:Osmolar Concentration; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects; D010062:Ovulation Induction / Q000379:methods / Q000662:veterinary; D011247:Pregnancy; D018873:Pregnancy Rate; D011270:Pregnancy, Animal; D011374:Progesterone / Q000032:analysis / Q000097:blood*; D013997:Time Factors
chemical_list: D006064:Gonadotropins, Equine; D011374:Progesterone; D015237:Dinoprost